Prescription Pharma Support Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue -28.01%
(FY 2023)
- Profit -68.24%
(FY 2023)
- Ebitda -66.34%
(FY 2023)
- Net Worth 10.14%
(FY 2023)
- Total Assets -13.29%
(FY 2023)
About Prescription Pharma Support
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Nagri, Asha Shetty, and Karen Carvalho serve as directors at the Company.
- CIN/LLPIN
U85190MH2008PTC188593
- Company No.
188593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Prescription Pharma Support Private Limited offer?
Prescription Pharma Support Private Limited offers a wide range of products and services, including HR & Manpower Recruitment Solutions, Aptitude Assessments, Project Feasibility Studies, Market Research Service, Graduation & High Education Programs, Management Courses, Business Planning and Management, Business Consultant, Corporate Training, Corporate Training Workshops.
Who are the key members and board of directors at Prescription Pharma Support?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karen Carvalho  | Director | 02-Dec-2008 | Current |
| Nikhil Nagri | Director | 02-Dec-2008 | Current |
| Asha Shetty | Director | 02-Dec-2008 | Current |
Financial Performance of Prescription Pharma Support.
Prescription Pharma Support Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.01% decrease. The company also saw a substantial fall in profitability, with a 68.24% decrease in profit. The company's net worth Soared by an impressive increase of 10.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prescription Pharma Support?
In 2023, Prescription Pharma Support had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prescription Pharma Support?
Unlock and access historical data on people associated with Prescription Pharma Support, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prescription Pharma Support, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prescription Pharma Support's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
